NEOGEN Corporation announced that the company had acquired the companion animal health company, CAPInnoVet, Inc. The acquisition would help NEOGEN to expand its portfolio in pet medications to the veterinary market.
Boehringer Ingelheim announced that its intramuscular needle-free device, FreVAX, can now be managed with the new version of FreVAX smartphone app.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 871
Published Date: Sep 05, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Growing demand for animal healthcare, advancements in technology and increasing prevalence of zoonotic diseases is driving the market growth.
The market size of Veterinary Injectable Devices is anticipated to attain a CAGR of 5.2% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are Boehringer Ingelheim., NuGen Medical Devices Inc, NEOGEN Corporation, Phibro Animal Health, Zoetis Inc, Japan International Cooperation Agency (JICA), DS Pharma Animal Health, Elanco, Mitsui & Co., Busan Animal Health Co. and others.
The disposable segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.